Advertisement

The Scientist

» industry and culture

Most Recent

image: HHS Partners on Ebola Drug

HHS Partners on Ebola Drug

By | July 22, 2015

The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space.

0 Comments

image: More Transparency in IRB-Industry Ties

More Transparency in IRB-Industry Ties

By | July 13, 2015

Conflicts of interest among institutional review board members are disclosed more often than they were a decade ago, according to a survey of academics.

0 Comments

image: CAR-T Therapies Get $1 Billion Boost

CAR-T Therapies Get $1 Billion Boost

By | July 1, 2015

The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.

0 Comments

image: Book Excerpt from <em>Faith vs. Fact</em>

Book Excerpt from Faith vs. Fact

By | July 1, 2015

In Chapter 1, “The Problem,” author Jerry Coyne sets the historical stage for his suggestion that science and religion are not compatible and never will be.

2 Comments

image: Capsule Reviews

Capsule Reviews

By | July 1, 2015

Stoned, Anxious, The Deeper Genome, and Testosterone

0 Comments

image: Speaking of Science

Speaking of Science

By | July 1, 2015

July 2015's selection of notable quotes

5 Comments

image: Staying Active in the Lab

Staying Active in the Lab

By | July 1, 2015

Retiring as a professor, and even shutting down your own lab, doesn’t necessarily mean quitting research.

8 Comments

image: The War Rages On

The War Rages On

By | July 1, 2015

Conflict between science and religion continues, with effects on health, politics, and the environment.

5 Comments

image: Keeping Science Pubs Clean

Keeping Science Pubs Clean

By | June 29, 2015

Science releases new guidelines for research transparency, hoping to stem the tide of retractions and misconduct.

0 Comments

image: Organ-on-a-Chip Gets Big Pharma Boost

Organ-on-a-Chip Gets Big Pharma Boost

By | June 18, 2015

Johnson & Johnson agrees to use Emulate’s blood-clot device in three of its preclinical drug programs.

0 Comments

Advertisement

Popular Now

  1. How Fats Influence the Microbiome
  2. Censored Professor Quits
    The Nutshell Censored Professor Quits

    Alice Dreger is resigning from the faculty of Northwestern University, claiming that the administration censored her work in a faculty journal.

  3. Opinion: Engineering the Epigenome
  4. Psychology’s Failure to Replicate
Advertisement
Mirus Bio
Mirus Bio
Advertisement